1 October 2019 in Clinical Nutrition ESPEN
1 June 2018 in Clinical Nutrition
6 January 2025 in Clinical Nutrition
A pragmatic trial and its secondary analyses have demonstrated that nutritional care not only reduces complications but also significantly improves survival in medical patients at risk of malnutrition. In contrast, for critically ill patients comparable evidence is scarce. Consequently, many propositions for refining the research agenda and study design in the field of critical care nutrition have already been made. The aim of this paper is to elucidate further critical problems in nutritional care. Critical appraisal of the literature from the past 70 years. We identified five key problems: 1. The immunologic background of catabolism 2. The energy goal during the acute phase 3. The quantification of endogenous substrate production 4. The incorporation of clinical and biological data into the study design, and 5. The energy goal and cardiopulmonary exercise testing during the recovery phase. The solution of these problems should supplement the propositions made by other authors and is essential to improving nutrition during and after critical care.
23 February 2026 in Nutrition in Clinical Practice
20 August 2019 in Aktuelle Ernahrungsmedizin
Aminosäuren sind die biologischen Baustoffe für alle Struktur- und Funktionsproteine. Da jede Erkrankung mit einem Abbau dieser Proteine einhergeht, ist die Zufuhr von Protein bzw. Aminosäuren essenziell für deren Resynthese. Derzeit gibt es keine Möglichkeit, die endogene Aminosäurefreisetzung zu bestimmen. So bleiben Zeitpunkt und Dosierung der Proteinzufuhr beim kritisch Kranken weiterhin Gegenstand der Diskussion. Critical illness is associated with a loss of body protein and skeletal muscle. Of 18 heterogenous randomized studies evaluating different doses of protein, 15 (83 %) found better results with a higher dose, which ranged from 1.1 to 3.6 g/kg/day. As the degree of catabolism varies with different diseases, there can be no optimal protein dose for all patients. However, clinical evidence is still week as only nitrogen balance was the primary endpoint in most of these trials. Observational studies showed a time dependency of the protein dose and lowest mortality with a dose ≥ 1.2 g/kg/day on and after day 4 or 6. However, in septic patients in the acute phase of infection the provision of > 1.2 g/kg/day of protein was associated with a higher mortality in one observational study. For future research, randomized studies should be performed on groups of patients with a defined protein loss. Also, protein dose should be related to lean body mass.
1 June 2020 in Aktuelle Ernahrungsmedizin
Nutrition for obese critically ill patients is still a controversial discussion. Latest guidelines give contradictory and partially unphysiological recommendations. Even if they agree on a hypocaloric, high protein feeding regimens, there is no agreement on the exact amount of energy and protein that should be provided for the obese patients. We describe a new concept of hypoalimentation which is based on the definition of lean body weight as well as protein dosing which is based on an estimation of the lean body mass. A comparison with traditional recommendation reveals the physiologic advantages of this new approach.